Divalproex Sodium Tablet, Extended Release
Product Images NDC 55111-533

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 55111-533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Divalproex Sodium Extended-release Tablets are a medication that comes in 250mg. The prescription information is written on the page with a warning to keep away from young children. There is also a reference to Dr. Reddy's pharmaceutical company, but no further details are provided.*

FDA Label Image

Container (Container)

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

This appears to be a table displaying a comparison of the improvement in CPS rate (which is not defined in the given text) between high dose and low dose formulations of delayed-release tablets of Divalproex Sodium. The table shows that the low dose formulation resulted in no change in CPS rate for 50% of patients, while the high dose formulation resulted in a reduction of CPS rate by 50%.*

FDA Label Image

Figure3 (Figure3)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.